1
|
Gavioli C, Vlooswijk C, Janssen SHM, Kaal SEJ, Kerst JM, Tromp JM, Bos MEMM, van der Hulle T, van der Graaf WTA, Lalisang RI, Nuver J, Bijlsma RM, Kouwenhoven MCM, Husson O, Beijer S. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study. J Cancer Surviv 2025; 19:1028-1042. [PMID: 38224397 DOI: 10.1007/s11764-023-01529-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Accepted: 12/27/2023] [Indexed: 01/16/2024]
Abstract
PURPOSE For adolescent and young adult (AYA) cancer survivors with a good prognosis, having a healthy lifestyle prevents morbidity and mortality after treatment. The aim of this study was to investigate the prevalence of (un)healthy lifestyle behaviors and related determinants in AYA cancer survivors. METHODS A population-based, cross-sectional study was performed among long-term (5-20 years) AYA cancer survivors (18-39 years old at diagnosis) registered within the Netherlands Cancer Registry. Self-reported questionnaires data about health behaviors were used to calculate the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) adherence score. Associations between the score and clinical/sociodemographic determinants of (un)healthy behaviors were investigated using logistic regression models. RESULTS The mean WCRF/AICR score was low to moderate, 3.8 ± 1.2 (0.5-7.0) (n = 3668). Sixty-one percent adhered to "limit the consumption of sugar sweetened drinks," 28% to "be a healthy weight," 25% to "fruit and vegetable consumption," and 31% to "limit alcohol consumption." Moderate and high adherence were associated with being a woman (ORmoderate = 1.46, 95% CI = 1.14-1.85, and ORhigh = 1.87, 95% CI = 1.46-2.4) and highly educated (ORmoderate = 1.54, 95% CI = 1.30-1.83, and ORhigh = 1.87, 95% CI = 1.46-2.4). Low adherence was associated with smoking (ORmoderate = 0.68, 95% CI = 0.50-0.92, and ORhigh = 0.30, 95% CI = 0.21-0.44) and diagnosis of germ cell tumor (ORmoderate = 0.58, 95% CI = 0.39-0.86, and ORhigh = 0.45, 95% CI = 0.30-0.69). CONCLUSIONS Adherence to the 2018 WCRF/AICR lifestyle recommendations was low to moderate, especially regarding body weight, fruit, vegetables, and alcohol consumption. Men, current smokers, lower-educated participants, and/or those diagnosed with germ cell tumors were less likely to have a healthy lifestyle. IMPLICATIONS FOR CANCER SURVIVORS Health-promotion programs (e.g., age-specific tools) are needed, focusing on high-risk groups.
Collapse
Affiliation(s)
- Costanza Gavioli
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands
| | - Carla Vlooswijk
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands
| | - Silvie H M Janssen
- Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands
- Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands
| | - Suzanne E J Kaal
- Department of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands
| | - J Martijn Kerst
- Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands
| | - Jacqueline M Tromp
- Department of Medical Oncology, Amsterdam University Medical Center, 1105 AZ, Amsterdam, The Netherlands
| | - Monique E M M Bos
- Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD, Rotterdam, The Netherlands
| | - Tom van der Hulle
- Department of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands
| | - Winette T A van der Graaf
- Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands
- Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD, Rotterdam, The Netherlands
| | - Roy I Lalisang
- Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, 6229 HX, Maastricht, The Netherlands
| | - Janine Nuver
- Department of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands
| | - Rhodé M Bijlsma
- Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands
| | - Mathilde C M Kouwenhoven
- Department of Neurology, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, The Netherlands
| | - Olga Husson
- Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
- Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.
- Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
| | - Sandra Beijer
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands
| |
Collapse
|
2
|
Wasse SK, Assogba E, Orazio S, Atsou KM, Rossi C, Guilloteau A, Gauthier S, Girard S, Poncet JM, Damaj G, Troussard X, Monnereau A, Dabakuyo-Yonli ST, Maynadie M. Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based Study. Cancers (Basel) 2025; 17:711. [PMID: 40002304 PMCID: PMC11853344 DOI: 10.3390/cancers17040711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2025] [Revised: 02/15/2025] [Accepted: 02/18/2025] [Indexed: 02/27/2025] Open
Abstract
Background/Objectives: Non-Hodgkin lymphoma (NHL) represents 63% of all hematological malignancies in France, with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) being the two most frequent forms. With the improvement of therapeutics, the issue of health-related quality of life (HRQoL) is becoming increasingly crucial for these patients. The aim was to compare HRQoL of NHL survivors with that of the general French population and to identify factors associated with HRQoL in NHL survivors. Methods: We conducted a population-based study among living patients from three registries of hematological malignancies, using standardized questionnaires, including the SF-12, in September 2023. The data collected were compared to those of a normative general French cohort. Results: In total, 493 patients completed the study questionnaires, yielding a response rate of 36%. The median time since diagnosis was 8 years (IQR 6-10) These NHL survivors reported lower HRQoL compared to the general French population, except in terms of bodily pain (p < 0.01). Each one-year increase in the time since diagnosis was associated with an increase in social functioning (p = 0.009). Men had better general health (p = 0.01) and less bodily pain (p = 0.007) than women. Higher income was associated with better HRQoL (p < 0.01). Underweight or obesity were associated with poorer physical functioning (p = 0.008). The presence of comorbidities, socioeconomic deprivation, anxiety, and depression were associated with poorer HRQoL (p < 0.01). Conclusions: This study provides valuable information of HRQoL values for comparison in further follow-up studies and proposes measures that could be implemented to improve the HRQoL of NHL survivors.
Collapse
Affiliation(s)
- Stephane Kroudia Wasse
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| | - Emerline Assogba
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
- Breast and Gynecologic Cancer Registry of Côte d’Or, Georges François Leclerc Comprehensive Cancer Centre, 21000 Dijon, France;
| | - Sebastien Orazio
- Registry of Hematological Malignancies of Gironde, Bergonié Institute, 33076 Bordeaux, France;
| | - Kueshivi Midodji Atsou
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| | - Cédric Rossi
- Clinical Hematology Unit, Dijon Bourgogne University Hospital, 21000 Dijon, France;
| | - Adrien Guilloteau
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| | - Sophie Gauthier
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| | - Stéphanie Girard
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| | - Jean-Marc Poncet
- Registry of Hematological Malignancies of Caen, Caen University Hospital, 14000 Caen, France; (J.-M.P.); (G.D.); (X.T.)
| | - Gandhi Damaj
- Registry of Hematological Malignancies of Caen, Caen University Hospital, 14000 Caen, France; (J.-M.P.); (G.D.); (X.T.)
- Clinical Hematology Unit, Caen University Hospital, 14000 Caen, France;
| | - Xavier Troussard
- Registry of Hematological Malignancies of Caen, Caen University Hospital, 14000 Caen, France; (J.-M.P.); (G.D.); (X.T.)
| | - Alain Monnereau
- Clinical Hematology Unit, Caen University Hospital, 14000 Caen, France;
| | - Sandrine Tienhan Dabakuyo-Yonli
- Breast and Gynecologic Cancer Registry of Côte d’Or, Georges François Leclerc Comprehensive Cancer Centre, 21000 Dijon, France;
- Clinical Hematology Unit, Dijon Bourgogne University Hospital, 21000 Dijon, France;
| | - Marc Maynadie
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France; (K.M.A.); (A.G.); (S.G.); (S.G.); (M.M.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France;
| |
Collapse
|
3
|
Tock WL, Johnson NA, Andersen RE, Salaciak M, Angelillo C, Loiselle CG, Hébert M, Maheu C. Pilot Randomized Controlled Trial of Lymfit: A Theory-Guided Exercise Intervention for Young Adults with Lymphoma. Healthcare (Basel) 2024; 12:1101. [PMID: 38891177 PMCID: PMC11171874 DOI: 10.3390/healthcare12111101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 05/24/2024] [Accepted: 05/26/2024] [Indexed: 06/21/2024] Open
Abstract
Despite the rapidly emerging evidence on the contributions of physical activity to improving cancer-related health outcomes, adherence to physical activity among young adults with lymphoma remains suboptimal. Guided by self-determination theory (SDT), the Lymfit intervention (a 12-week individualized exercise program with bi-weekly kinesiologist support and an activity tracker) aimed to foster autonomous motivation toward physical activity. This pilot randomized controlled trial aimed to evaluate the feasibility, acceptability, and preliminary effects of Lymfit. Young adults (N = 26; mean age of 32.1 years) with lymphoma who were newly diagnosed and those up to six months after completing treatment were recruited and randomly assigned one-to-one to either the intervention group (n = 13) or a wait-list control group (n = 13). All a priori feasibility benchmarks were met, confirming the feasibility of the study in terms of recruitment uptake, retention, questionnaire completion, intervention fidelity, missing data, Fitbit wear adherence, and control group design. The intervention acceptability assessment showed high ratings, with eight out of ten items receiving >80% high ratings. At post-intervention, an analysis of covariance models showed a clinically significant increase in self-reported physical activity levels, psychological need satisfaction, and exercise motivation in the intervention group compared to controls. Lymfit also led to meaningful changes in six quality-of-life domains in the intervention group, including anxiety, depression, fatigue, sleep disturbance, social roles and activities, and pain interference. The findings support Lymfit as a promising means to meet psychological needs and increase the autonomous motivation for physical activity in this group. A fully powered efficacy trial is warranted to assess the validity of these findings.
Collapse
Affiliation(s)
- Wing Lam Tock
- Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3A 2M7, Canada; (C.G.L.); (C.M.)
| | - Nathalie A. Johnson
- Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada;
- Department of Medicine, Jewish General Hospital, Montréal, QC H3T 1E2, Canada
| | - Ross E. Andersen
- Department of Kinesiology and Physical Education, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H2W 1S4, Canada; (R.E.A.); (C.A.)
| | - Matthew Salaciak
- Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3G 2M1, Canada;
| | - Christopher Angelillo
- Department of Kinesiology and Physical Education, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H2W 1S4, Canada; (R.E.A.); (C.A.)
| | - Carmen G. Loiselle
- Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3A 2M7, Canada; (C.G.L.); (C.M.)
- Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3J1, Canada;
- Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H4A 3T2, Canada
| | - Maude Hébert
- Département des Sciences Infirmières, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada;
| | - Christine Maheu
- Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3A 2M7, Canada; (C.G.L.); (C.M.)
| |
Collapse
|
4
|
Wasse SK, Mounier M, Assogba E, Rossi C, Adnet J, Gauthier S, Girard S, Atsou KM, Dabakuyo-Yonli TS, Maynadie M. Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study. Cancers (Basel) 2023; 15:3885. [PMID: 37568701 PMCID: PMC10417301 DOI: 10.3390/cancers15153885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 07/24/2023] [Accepted: 07/27/2023] [Indexed: 08/13/2023] Open
Abstract
PURPOSE To describe Health-Related Quality of Life (HRQoL) and to identify the association between sociodemographic, clinical and psychosocial factors, and self-reported HRQoL among NHL survivors. METHODS The data of the cancer registry specialized in hematological malignancies in Côte d'Or (France) were used to identify all patients diagnosed with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) from 2010 to 2017. Patients were invited to complete SF-12 and other questionnaires. RESULTS The HRQoL of NHL survivors was poorer than that of the French general population (p < 0.05) in vitality (48 vs. 56), general health (56 vs. 63), role physical scores (60 vs. 70), role emotional scores (64 vs. 72) and the Mental Component Scale (45 vs. 49). The mean difference in physical functioning decreased per unit increase in age (β = -1.1 (0.3); p < 0.001). Men had better vitality than women (β = 12.4 (6.1); p = 0.04) and the high education level was associated with greater role emotional scores (β = 14.1 (5.4); p = 0.01). Symptoms of anxiety and depression were associated with poorer HRQoL. The satisfaction of social support was associated with significantly greater scores on mental health (β = 17.3 (5.1); p = 0.001) and social functioning (β = 15.7 (7.8); p = 0.04). Socioeconomic deprivation was associated with poorer general health (β = -12.8 (5.2); p = 0.01). CONCLUSIONS From 3 to 11 years post-diagnosis, the main factors found to be associated with poor HRQoL of NHL survivors were age, sex, presence of anxiety, depression and economic problems. These findings suggest the need for supportive care to improve HRQOL and the consideration of these problems when developing care plans for NHL survivors.
Collapse
Affiliation(s)
- Stephane Kroudia Wasse
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| | - Morgane Mounier
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| | - Emerline Assogba
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
- Breast and Gynaecologic Cancer Registry of Côte d’Or, Georges François Leclerc Comprehensive Cancer Centre, F-21000 Dijon, France
| | - Cédric Rossi
- Clinical Hematology Unit, Dijon Bourgogne University Hospital, F-21000 Dijon, France;
| | - Johan Adnet
- Methodology Biostatistics and Data-Management Unit, Georges François Leclerc Comprehensive Cancer Centre, F-21000 Dijon, France;
| | - Sophie Gauthier
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| | - Stephanie Girard
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| | - Kueshivi Midodji Atsou
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| | - Tienhan Sandrine Dabakuyo-Yonli
- Breast and Gynaecologic Cancer Registry of Côte d’Or, Georges François Leclerc Comprehensive Cancer Centre, F-21000 Dijon, France
- National Quality of Life and Cancer Clinical Research Platform, F-21000 Dijon, France
| | - Marc Maynadie
- Registry of Hematological Malignancies of Côte d’Or, Dijon-Bourgogne University Hospital, F-21000 Dijon, France; (M.M.); (S.G.); (S.G.); (K.M.A.)
- INSERM, UMR1231, Bourgogne Franche-Comté University, F-21000 Dijon, France;
| |
Collapse
|
5
|
Leach MJ, Barber G, Monacella S, Jamieson P, Trinh T, Vo N, Schmidt U, Byrne A, Ristevski E. Physical activity, obesity, and quality of life among rural Australian cancer survivors: a cross-sectional study. Support Care Cancer 2023; 31:222. [PMID: 36939924 PMCID: PMC10027785 DOI: 10.1007/s00520-023-07691-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Accepted: 03/13/2023] [Indexed: 03/21/2023]
Abstract
PURPOSE We aimed to describe physical activity (PA), obesity, and quality of life (QoL) among rural Australian cancer survivors, assess whether total and item-specific QoL are associated with sufficient PA and obesity, and assess whether PA and obesity interact with respect to QoL. METHODS In a cross-sectional study, convenience sampling was used to recruit adult cancer survivors via a chemotherapy day unit and allied health professionals at a rural hospital in Baw Baw Shire, Australia. Exclusion criteria were acute malnutrition and end-of-life care. PA and QoL were measured using Godin-Shephard and 7-item Functional Assessment of Cancer Therapy (FACT-G7) questionnaires, respectively. Factors associated with total and item-specific QoL were assessed via linear and logistic regression, respectively. RESULTS Among 103 rural cancer survivors, the median age was 66 years, 35% were sufficiently physically active, and 41% presented with obesity. Mean/median total QoL scores were 17 on the FACT-G7 scale (0-28; higher scores indicate better QoL). Sufficient PA was associated with better QoL ([Formula: see text]=2.29; 95% confidence interval [CI] = 0.26, 4.33) and more energy (odds ratio [OR] = 4.00, 95% CI = 1.48, 10.78) while obesity was associated with worse QoL ([Formula: see text]=-2.09; 95% CI = -4.17, -0.01) and more pain (OR = 3.88, 95% CI = 1.29, 11.68). The PA-obesity interaction was non-significant (p-value = 0.83). CONCLUSIONS This is the first known study conducted among rural survivors of any cancer to find sufficient PA and obesity are associated with better and worse QoL, respectively. PA, weight management, and QoL-including energy and pain-should be considered when targeting and tailoring supportive care interventions for rural cancer survivors.
Collapse
Affiliation(s)
- Michael J Leach
- School of Rural Health, Monash University, Warragul, Bendigo, VIC, Australia.
| | | | | | | | - Thi Trinh
- West Gippsland Healthcare Group, Warragul, VIC, Australia
| | - Ngan Vo
- West Gippsland Healthcare Group, Warragul, VIC, Australia
| | - Ulla Schmidt
- West Gippsland Healthcare Group, Warragul, VIC, Australia
| | - Anny Byrne
- West Gippsland Healthcare Group, Warragul, VIC, Australia
| | - Eli Ristevski
- School of Rural Health, Monash University, Warragul, VIC, Australia
| |
Collapse
|